China Feihe firmly holds the first place in both market share and sales across all channels, with a revenue of 9.15 billion yuan in the first half of the year

China Feihe released its mid-term performance report for 2025, with revenue of 9.15 billion yuan, net profit of 1.03 billion yuan, and cash flow of 6.48 billion yuan. The company continues to maintain its first position in the infant formula market, with a 270% increase in the number of overseas stores. China Feihe plans to repurchase 1 billion yuan of shares and distribute approximately 1 billion yuan in mid-term dividends, with total dividends expected to be no less than 2 billion yuan in 2025. In addition, the company has launched a 1.2 billion yuan fertility subsidy plan, expected to benefit 800,000 newborn families